Refine Search

New Search

Results in Journal Drug Designing & Intellectual Properties International Journal: 48

(searched for: journal_id:(4148092))
Page of 1
Articles per Page
by
Show export options
  Select all
Yuri S Pestovsky
Drug Designing & Intellectual Properties International Journal, Volume 3, pp 293-327; doi:10.32474/ddipij.2018.03.000155

Abstract:
Alginates are polysaccharides. The commercially available ones come from brown algae
Snehasis Jana, Alice Branton, Mahendra Kumar Trivedi, Dahryn Trivedi, Gopal Nayak
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-8; doi:10.32474/ddipij.2019.02.000149

Gopal Dixit
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-2; doi:10.32474/ddipij.2019.02.000148

, Nur Kabidul Azam
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-2; doi:10.32474/ddipij.2019.02.000147

Isak R Shaikh
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-9; doi:10.32474/ddipij.2018.02.000145

François-Xavier Lacasse
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-3; doi:10.32474/ddipij.2018.02.000144

Tabrez Shaikh, Amit Gosar, Hussain Sayyed
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-6; doi:10.32474/ddipij.2018.02.000143

Ruiz Loyola Benjamín
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-3; doi:10.32474/ddipij.2018.02.000142

Mohsen Amani, , Rabih Chahine
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-3; doi:10.32474/ddipij.2018.02.000141

A Krishna Sailaja
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-5; doi:10.32474/ddipij.2018.02.000140

Isaac John Umaru, Fasihuddin Badruddin Ahmed, Hauwa A Umaru, Kerenhappuch I Umaru, Benedict Samling
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-10; doi:10.32474/ddipij.2018.02.000138

Gomaa Hossam Mohammed, Hossam Mohammed Gomaa, Ahmed Hatim Hamdy El-Dosokey
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-10; doi:10.32474/ddipij.2018.02.000139

Robert Skopec
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-6; doi:10.32474/ddipij.2018.02.000137

, Nahd Mohamed ElMaki, Inass A Al Sadawi,
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-4; doi:10.32474/ddipij.2018.02.000136

D Kapoor, Kapoor D, Vyas Rb, Dadrwal D
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-6; doi:10.32474/ddipij.2018.02.000135

Cauê Benito Scarim
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-3; doi:10.32474/ddipij.2018.02.000134

Kholmuradova Mushtariy
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-2; doi:10.32474/ddipij.2018.02.000133

Isaac John Umaru, , Kayode Arowora, Silas Verwiyah Tatah, Hauwa A Umaru
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-4; doi:10.32474/ddipij.2018.02.000131

Robert Skopec
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-4; doi:10.32474/ddipij.2018.02.000129

Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-2; doi:10.32474/ddipij.2018.02.000128

Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-3; doi:10.32474/ddipij.2018.02.000127

Abstract:
During the last decades, life science startup companies have relatively rapidly increased their presence in the pharmaceutical landscape. Pharmaceutical
Rahul Hajare
Drug Designing & Intellectual Properties International Journal, Volume 2, pp 1-2; doi:10.32474/ddipij.2018.02.000126

Dina Louis, Mahmoud Kamal, Mohamed Maher, Amr Ibrahim
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 1-9; doi:10.32474/ddipij.2018.01.000125

Abstract:
As of late, vesicles have turned out to become the vehicle of choice in drug delivery. Lipid vesicles have important role in improving bioavailability for existing drugs
Joydeep Dhar
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 1-3; doi:10.32474/ddipij.2018.01.000124

Abstract:
Inability to early diagnosis is a major concern for the treatment of fatal disease like cancer. Early diagnosis and treatment enhances the scope of disease curability
Suresh Kumar
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 1-4; doi:10.32474/ddipij.2018.01.000123

Chang Rok Jeong
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 1-3; doi:10.32474/ddipij.2018.01.000121

Abstract:
On November 21, 2010, a four-year-old girl visited the emergency room of Kyungpook national university hospital and could not receive treatment because she did not have a pediatrician
Isaac John Umaru, Fasihuddin A Badruddin, Hauwa A Umaru
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 1-5; doi:10.32474/ddipij.2018.01.000122

Ayoub Ainane, , M’Hamed Elkouali, , El Hassan Abba, Sanaa Cherroud, Adnane Elyaacoubi, Khadija Oumaskour, Nabila Boujaber, Said Benhar, et al.
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 1-4; doi:10.32474/ddipij.2018.01.000120

Calabrese Mariaconsiglia, M Garofano, Mm Ascoli, M Ciriello, M Aliberti, M Calabrese
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 1-3; doi:10.32474/ddipij.2018.01.000119

Ofra Benny
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 1-3; doi:10.32474/ddipij.2018.01.000118

Carmen Gruber Traub
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 1-3; doi:10.32474/ddipij.2018.01.000116

Silvia A Brandán
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 1-18; doi:10.32474/ddipij.2018.01.000114

Robert Skopec
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 1-5; doi:10.32474/ddipij.2018.01.000113

Subhajit Ghosh, Pn Murthy, H Joshi
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 1-6; doi:10.32474/ddipij.2018.01.000111

Francois Xavier Lacasse
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 1-3; doi:10.32474/ddipij.2018.01.000110

Abstract:
During the last decade, and exponentially over the last three years, numerous pharmaceutical manufacturing plants have closed their doors following current
Keo Samell
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 001-005; doi:10.32474/ddipij.2018.01.000109

Athir M Haddad
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 001-008; doi:10.32474/ddipij.2018.01.000108

Devesh Kapoor
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 001-014; doi:10.32474/ddipij.2018.01.000107

V. K. Singh
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 001-006; doi:10.32474/ddipij.2018.01.000104

Reza Farahani Mohammad
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 001-004; doi:10.32474/ddipij.2018.01.000102

Kpr Chowdary
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 001-003; doi:10.32474/ddipij.2018.01.000103

Abstract:
The design of micro particulate drug delivery systems is an efficient technique to provide the sustained & controlled delivery of drugs over long periods of time
Francois Xavier Lacasse
Drug Designing & Intellectual Properties International Journal, Volume 1, pp 001-005; doi:10.32474/ddipij.2018.01.000101

Page of 1
Articles per Page
by
Show export options
  Select all
Back to Top Top